TY - JOUR
T1 - Evolutionary dynamics of HIV at multiple spatial and temporal scales
AU - Hill, Alison L.
AU - Rosenbloom, Daniel I.S.
AU - Nowak, Martin A.
N1 - Funding Information:
Acknowledgments We are grateful for the support from the National Science Foundation/National Institutes of Health joint program in mathematical biology (M.A.N., A.L.H.), the Bill & Melinda Gates Foundation (M.A.N., A.L.H.), a National Science Foundation Graduate Research Fellowship (D.I.S.R.), the John Templeton Foundation (M.A.N.), and J. Epstein (M.A.N.). We thank Pleuni Pennings, Alal Eran, Alireza Rabi, and two anonymous reviewers for helpful comments with the manuscript.
PY - 2012/5
Y1 - 2012/5
N2 - Infectious diseases remain a formidable challenge to human health, and understanding pathogen evolution is crucial to designing effective therapeutics and control strategies. Here, we review important evolutionary aspects of HIV infection, highlighting the concept of selection at multiple spatial and temporal scales. At the smallest scale, a single cell may be infected by multiple virions competing for intracellular resources. Recombination and phenotypic mixing introduce novel evolutionary dynamics. As the virus spreads between cells in an infected individual, it continually evolves to circumvent the immune system. We discuss evolutionary mechanisms of HIV pathogenesis and progression to AIDS. Viral spread throughout the human population can lead to changes in virulence and the transmission of immune-evading variation. HIV emerged as a human pathogen due to selection occurring between different species, adapting from related viruses of primates. HIV also evolves resistance to antiretroviral drugs within a single infected host, and we explore the possibility for the spread of these strains between hosts, leading to a drug-resistant epidemic. We investigate the role of latency, drug-protected compartments, and direct cell-to-cell transmission on viral evolution. The introduction of an HIV vaccine may select for viral variants that escape vaccine control, both within an individual and throughout the population. Due to the strong selective pressure exerted by HIV-induced morbidity and mortality in many parts of the world, the human population itself may be co-evolving in response to the HIV pandemic. Throughout the paper, we focus on trade-offs between costs and benefits that constrain viral evolution and accentuate how selection pressures differ at different levels of selection.
AB - Infectious diseases remain a formidable challenge to human health, and understanding pathogen evolution is crucial to designing effective therapeutics and control strategies. Here, we review important evolutionary aspects of HIV infection, highlighting the concept of selection at multiple spatial and temporal scales. At the smallest scale, a single cell may be infected by multiple virions competing for intracellular resources. Recombination and phenotypic mixing introduce novel evolutionary dynamics. As the virus spreads between cells in an infected individual, it continually evolves to circumvent the immune system. We discuss evolutionary mechanisms of HIV pathogenesis and progression to AIDS. Viral spread throughout the human population can lead to changes in virulence and the transmission of immune-evading variation. HIV emerged as a human pathogen due to selection occurring between different species, adapting from related viruses of primates. HIV also evolves resistance to antiretroviral drugs within a single infected host, and we explore the possibility for the spread of these strains between hosts, leading to a drug-resistant epidemic. We investigate the role of latency, drug-protected compartments, and direct cell-to-cell transmission on viral evolution. The introduction of an HIV vaccine may select for viral variants that escape vaccine control, both within an individual and throughout the population. Due to the strong selective pressure exerted by HIV-induced morbidity and mortality in many parts of the world, the human population itself may be co-evolving in response to the HIV pandemic. Throughout the paper, we focus on trade-offs between costs and benefits that constrain viral evolution and accentuate how selection pressures differ at different levels of selection.
KW - Coevolution
KW - Drug resistance
KW - Evolutionary dynamics
KW - HIV
KW - Immune escape
KW - Virulence
UR - http://www.scopus.com/inward/record.url?scp=84862514242&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862514242&partnerID=8YFLogxK
U2 - 10.1007/s00109-012-0892-1
DO - 10.1007/s00109-012-0892-1
M3 - Review article
C2 - 22552382
AN - SCOPUS:84862514242
SN - 0946-2716
VL - 90
SP - 543
EP - 561
JO - Journal of Molecular Medicine
JF - Journal of Molecular Medicine
IS - 5
ER -